H. Mascher

发表

A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease

S. Eichler, A. Rolfs, A. Giese, 2015, Orphanet Journal of Rare Diseases.

Comparison of UV and tandem mass spectrometric detection for the high-performance liquid chromatographic determination of diclofenac in microdialysis samples.

Markus Müller, H. Mascher, P. Dehghanyar, 2003, Journal of pharmaceutical and biomedical analysis.

The pharmacokinetics of a new sustained-release form of diclofenac sodium in humans.

H. Mascher, 1989, Drug design and delivery.

High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine.

E. Schmid, G. Scherer, H. Mascher, 2001, Journal of Chromatography B: Biomedical Sciences and Applications.

Diclofenac concentrations in defined tissue layers after topical administration

H. Eichler, G. Dorner, M. Brunner, 1997, Clinical pharmacology and therapeutics.

Exposure patterns of UV filters, fragrances, parabens, phthalates, organochlor pesticides, PBDEs, and PCBs in human milk: correlation of UV filters with use of cosmetics.

M. Wittassek, J. Angerer, M. Schlumpf, 2010, Chemosphere.

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.

J. Bousquet, U. Munzel, H. Derendorf, 2012, British journal of clinical pharmacology.

Treatment of advanced colorectal cancer with folinic acid and 5-fluorouracil in combination with cisplatinum.

H. Umek, M. Micksche, R. Essl, 1994, European journal of cancer.

Determination of amoxicillin in plasma by high-performance liquid chromatography with fluorescence detection after online oxidation.

H. Mascher, C. Kikuta, 1990, Journal of chromatography.

Clonidine added to bupivacaine enhances and prolongs analgesia after brachial plexus block via a local mechanism in healthy volunteers

L. Schmetterer, H. Eichler, E. Tschernko, 2004, European journal of anaesthesiology.

Lyso-globotriaosylsphingosine (lyso-Gb3) levels in neonates and adults with the Fabry disease later-onset GLA IVS4+919G>A mutation

Y. Chien, W. Hwu, O. Bodamer, 2013, Journal of Inherited Metabolic Disease.

Pharmacokinetics and bioequivalence of the main metabolites of selegiline: desmethylselegiline, methamphetamine and amphetamine after oral administration of selegiline.

H. Mascher, C. Kikuta, H. Schiel, 1997, International journal of clinical pharmacology and therapeutics.

Lyso-Gb3 Indicates that the Alpha-Galactosidase A Mutation D313Y is not Clinically Relevant for Fabry Disease.

C. Wanner, F. Weidemann, A. Rolfs, 2013, JIMD reports.

Lack of Pharmacokinetic and Pharmacodynamic Interaction Between Pantoprazole and Glibenclamide in Humans

I. Walter‐Sack, W. Wurst, V. Steinijans, 1998 .

Sensitive simultaneous determination of ciclesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC-MS/MS with APPI.

H. Mascher, D. Mascher, K. Zech, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

A FIM Study to Assess Safety and Exposure of Inhaled Single Doses of AP301—A Specific ENaC Channel Activator for the Treatment of Acute Lung Injury

M. Zeitlinger, R. Lucas, R. Hermann, 2014, Journal of clinical pharmacology.

Frequency of Fabry disease in patients with small‐fibre neuropathy of unknown aetiology: a pilot study

M. Kaps, K. Lackner, A. Rolfs, 2011, European journal of neurology.

Endogenous plasma N‐acetylcysteine and single dose oral bioavailability from two different formulations as determined by a new analytical method

H. Mascher, B. Gabard, Bernard Gabard, 1991, Biopharmaceutics & drug disposition.

Determination of neomycin and bacitracin in human or rabbit serum by HPLC-MS/MS.

H. Mascher, D. Mascher, Christian P Unger, 2007, Journal of pharmaceutical and biomedical analysis.

Topical skin penetration of diclofenac after single- and multiple-dose application.

M. Brunner, H. Mascher, P. Dehghanyar, 2004, International journal of clinical pharmacology and therapeutics.

Pharmacokinetics of Menthol and Carvone after Administration of an Enteric Coated Formulation Containing Peppermint Oil and Caraway Oil

H. Mascher, C. Kikuta, H. Schiel, 2001, Arzneimittelforschung.

Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay.

H. Mascher, R. Weyhenmeyer, J. Birkmayer, 1992, International journal of clinical pharmacology, therapy, and toxicology.

Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution‐ and absorption rates in the lungs

Maria Malmlöf, E. Selg, H. Mascher, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Analysis of Lyso-Globotriaosylsphingosine in Dried Blood Spots

Y. Chien, W. Hwu, O. Bodamer, 2013, Annals of laboratory medicine.

Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats.

H. Heinzl, H. Mascher, S. Walser, 1997, Arzneimittel-Forschung.

Pharmacokinetics and bioavailability of different formulations of aciclovir.

H. Mascher, C. Kikuta, H. Vergin, 1995, Arzneimittel-Forschung.

Long-term stability of amino acids and acylcarnitines in dried blood spots.

Georg Heinze, Sylvia Stöckler-Ipsiroglu, G. Heinze, 2007, Clinical chemistry.

Endocrinology and Metabolism: Long-Term Stability of Amino Acids and Acylcarnitines in Dried Blood Spots

F. Waldhauser, O. Bodamer, S. Stöckler‐Ipsiroglu, 2007 .

[5-Methoxypsoralen: bioavailability and pharmacokinetics].

H. Mascher, V. Nitsche, 1982, Arzneimittel-Forschung.

Measuring sucrose in blood after oral administration to detect abomasal ulcers in calves

M. Dolezal, A. Hund, T. Wittek, 2019, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Determination of norfloxacin in human plasma and urine by high-performance liquid chromatography and fluorescence detection.

H. Mascher, C. Kikuta, 1998, Journal of chromatography. A.

Glucosylsphingosine Is a Highly Sensitive and Specific Biomarker for Primary Diagnostic and Follow-Up Monitoring in Gaucher Disease in a Non-Jewish, Caucasian Cohort of Gaucher Disease Patients

M. Wittstock, A. Rolfs, A. Giese, 2013, PloS one.

Determination of codeine in human plasma by reverse-phase high-performance liquid chromatography.

H. Mascher, V. Nitsche, 1984, Journal of pharmaceutical sciences.

High-performance liquid chromatography determination of total thiamin in human plasma.

H. Mascher, C. Kikuta, 1997, Methods in enzymology.

Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease

K. Lackner, A. Rolfs, A. Giese, 2013, PLoS genetics.

Broad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA gene

M. Wittstock, K. Lackner, A. Rolfs, 2012, Clinical kidney journal.

Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons

M. Frech, A. Rolfs, M. Frank, 2017, Brain Research.

New, high-sensitivity high-performance liquid chromatographic method for the determination of acyclovir in human plasma, using fluorometric detection.

H. Mascher, C. Kikuta, H. Vergin, 1992, Journal of chromatography.

Separation, isolation and identification of optical isomers of 1,4-benzodiazepine glucuronides from biological fluids by reversed-phase high-performance liquid chromatography.

H. Mascher, V. Nitsche, H. Schütz, 1984, Journal of chromatography.

Nonketotic hyperglycinemia

G. Dumermuth, R. Gitzelmann, B. Steinmann, 1993, Neurology.

HPLC-determination of nifedipine in plasma on normal phase

H. Mascher, H. Vergin, 1988 .

Bioavailability of a crushed pantoprazole tablet after buffering with sodium hydrogencarbonate or magaldrate relative to the intact enteric coated pantoprazole tablet.

H. Mascher, P. Sander, P. Lücker, 2001, Methods and findings in experimental and clinical pharmacology.

Diastereomeric Separation of Free and Conjugated Silibinin in Plasma by Reversed Phase HPLC After Specific Extraction

H. Mascher, C. Kikuta, R. Weyhenmeyer, 1993 .

The Pharmacokinetics of Valproic Acid After Oral and Parenteral Administration in Healthy Volunteers

H. Mascher, V. Nitsche, 1982, Epilepsia.

Determination of total pyridoxal in human plasma following oral administration of vitamin B6 by high-performance liquid chromatography with post-column derivatization.

H. Mascher, 1993, Journal of pharmaceutical sciences.

High-performance liquid chromatographic determination of total thiamine in human plasma for oral bioavailability studies.

H. Mascher, H Mascher, C Kikuta, 1993, Journal of pharmaceutical sciences.

Acute Cerebrovascular Disease in the Young: The Stroke in Young Fabry Patients Study

G. Deuschl, A. Metz, D. Krieger, 2013, Stroke.

High-performance liquid chromatographic determination of dextrorphan and 3-hydroxymorphinan in human plasma based on a selective pre-column sample clean-up.

H. Mascher, 1987, Journal of Chromatography A.

Determination of minocycline in human plasma by high-performance liquid chromatography with UV detection after liquid-liquid extraction.

H. Mascher, 1998, Journal of chromatography. A.

Determination of amoxicillin in human serum and plasma by high-performance liquid chromatography and on-line postcolumn derivatisation.

H. Mascher, C. Kikuta, 1998, Journal of chromatography. A.

Rapid high-performance liquid chromatographic assay of cinnarizine in human plasma.

H. Mascher, V. Nitsche, 1982, Journal of chromatography.

Morphological Alterations of the Cornea in the Mouse Model of Niemann–Pick Disease Type C1

M. Frech, A. Rolfs, J. Lukas, 2011, Cornea.

Lack of pharmacokinetic interaction between pantoprazole and diclofenac.

W. Wurst, V. Steinijans, H. Mascher, 1996, International journal of clinical pharmacology and therapeutics.

Simple and fast HPLC method for the determination of triamterene and hydroxytriamterenesulphate in plasma and urine

M. Wasilewski, H. Mascher, 1994 .

Intra‐oesophageal pH profiles and pharmacokinetics of pantoprazole and esomeprazole: a crossover study in patients with gastro‐oesophageal reflux disease

H. Mascher, P. Sander, G. Gatz, 2003, European journal of gastroenterology & hepatology.

Comparison of the pharmacodynamics and pharmacokinetics of pantoprazole (40 mg) as compared to omeprazole MUPS (20 mg) after repeated oral dose administration.

H. Mascher, P. Sander, P. Lücker, 1999, Methods and findings in experimental and clinical pharmacology.

Comparative bioavailability of several phenytoin preparations marketed in Austria.

H. Mascher, V. Nitsche, H. Schütz, 1984, International journal of clinical pharmacology, therapy and toxicology.

New rapid assay of cimetidine in human plasma by reversed-phase high-performance liquid chromatography.

H. Mascher, V. Nitsche, 1983, Journal of Chromatography A.

Ultra-sensitive determination of Formoterol in human serum by high performance liquid chromatography and electrospray tandem mass spectrometry.

H. Mascher, D. Mascher, R. Nave, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Endurance Exercise Training and L-Carnitine Supplementation Stimulates Gene Expression in the Blood and Muscle Cells in Young Athletes and Middle Aged Subjects

M. Eder, H. Mascher, D. Mascher, 2005 .

Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum.

Thomas Pfeifer, Philip Timmerman, Pascal Delrat, 2014, Bioanalysis.

A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease

S. Eichler, A. Rolfs, A. Giese, 2015 .

Pantoprazole lacks induction of CYP1A2 activity in man.

W. Wurst, V. Steinijans, H. Mascher, 1999, International journal of clinical pharmacology and therapeutics.

Determination of Desmethyl- Selegiline, Methamphetamine and Amphetamine - The Main Metabolites of Selegiline in Plasma by HPLC After Derivatization

H. Mascher, C. Kikuta, B. Göd, 1997 .

Pantoprazole does not interact with the pharmacokinetics of carbamazepine.

W. Wurst, V. Steinijans, H. Mascher, 1998, International journal of clinical pharmacology and therapeutics.

Pantoprazole has no influence on steady state pharmacokinetics and pharmacodynamics of metoprolol in healthy volunteers.

W. Wurst, H. Mascher, M. Hartmann, 1996, International journal of clinical pharmacology and therapeutics.